Ackerstein Group Ltd (TLV:ACKR)
864.10
-12.50 (-1.43%)
Jul 31, 2025, 5:24 PM IDT
Revance Therapeutics Revenue
Ackerstein Group had revenue of 230.46M ILS in the quarter ending March 31, 2025, with 18.74% growth. This brings the company's revenue in the last twelve months to 938.72M, down -3.87% year-over-year. In the year 2024, Ackerstein Group had annual revenue of 902.35M, down -12.98%.
Revenue (ttm)
938.72M
Revenue Growth
-3.87%
P/S Ratio
2.66
Revenue / Employee
1.71M
Employees
549
Market Cap
2.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 902.35M | -134.61M | -12.98% |
Dec 31, 2023 | 1.04B | 254.71M | 32.56% |
Dec 31, 2022 | 782.25M | 141.76M | 22.13% |
Dec 31, 2021 | 640.49M | -22.28M | -3.36% |
Dec 31, 2020 | 662.77M | -16.82M | -2.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Israel Corporation | 25.59B |
Turpaz Industries | 783.02M |
Inrom Construction Industries | 1.24B |
Polyram Plastic Industries LTD | 996.24M |
Mendelson Infrastructures & Industries | 1.04B |
Kafrit Industries (1993) | 1.36B |
Hod Assaf Industries | 2.20B |
Klil Industries | 335.21M |